Literature DB >> 14527308

Nonsyndromic seizure disorders: epilepsy and the use of the internet to advance research.

Mark F Leppert1, Nanda A Singh.   

Abstract

The progress in understanding the genetics of nonsyndromic epilepsy is the direct result of dramatic advances made by the Human Genome Project. The development of thousands of precisely mapped genetic markers and the nearly complete sequencing of the entire human genome in 2001 allowed genetic researchers in epilepsy to identify many loci and genes as causal in inherited idiopathic epilepsy. This substantial increase in information has required the development of accurate and online bioinformatic databases. Only the Internet can enable such large amounts of precise DNA sequence information to be transferred to researchers. Along with the construction of these databases has been the development of efficient search algorithms for specific DNA sequences and genetic information. This article summarizes the effect that this burst of new genomic information has had on research aimed at discovering the underlying genetic factors for nonsyndromic epilepsy. Many of the web sites important to epilepsy gene discovery are listed and discussed in this article, including sites with extensive information on genetic markers, genetic analysis, gene sequence, gene expression, gene mutations, and DNA sequence variation. Continued acquisition of information on naturally occurring DNA sequence variants will greatly help research directed towards understanding the genetic susceptibility of the common, nonsyndromic epilepsies and will lead to the promise of personalized medicine.

Entities:  

Mesh:

Year:  2003        PMID: 14527308     DOI: 10.1146/annurev.genom.4.071902.102155

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  1 in total

1.  An XML-based system for synthesis of data from disparate databases.

Authors:  Tahsin Kurc; Daniel A Janies; Andrew D Johnson; Stephen Langella; Scott Oster; Shannon Hastings; Farhat Habib; Terry Camerlengo; David Ervin; Umit V Catalyurek; Joel H Saltz
Journal:  J Am Med Inform Assoc       Date:  2006-02-24       Impact factor: 4.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.